We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Withdrawals in EU Must Be Justified Under New Pharmacovigilance Rules
Drug Withdrawals in EU Must Be Justified Under New Pharmacovigilance Rules
October 8, 2012
Manufacturers withdrawing their drugs from any market in the EU will now have to notify competent authorities of the reason, according to amended pharmacovigilance rules adopted by the Council of the European Union Oct. 4.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor